Is Wall Street Bullish or Bearish on Cencora Stock?

Conshohocken, Pennsylvania-based Cencora, Inc. (COR) sources and distributes pharmaceutical products in the United States and internationally. Valued at a market cap of $65 billion, the company distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, and more.

Shares of Cencora have lagged behind the broader market over the past year, surging 11.7% compared to the S&P 500 Index’s ($SPX) 19.9% surge. Moreover, in 2026, the stock has fallen by nearly 4.4%, also underperforming SPX’s 12.9% gain.